A global analysis links DEHP and similar phthalates to nearly 2 million premature births and roughly 74,000 newborn deaths in 2018, and U.S. studies point to tens of thousands of domestic cases.

Consumer Reports found popular home lead-test kits flag high contamination but often miss lower, still-dangerous levels. Officials say certified lab testing is the reliable way to confirm lead.

USCIS has added medical physicians to a narrow list that may resume processing, giving some hospitals relief while thousands of other applicants stay on hold. The pause still blocks researchers and entrepreneurs from dozens of countries.

A Fort Worth veteran says TRICARE approvals were reversed after TriWest took over the West Region, leaving patients with unpaid bills and delayed care.

U.S. life expectancy hit 79, but longer lives mean more years of costly care — and many households aren't ready.

Three people died and several others fell ill after a suspected hantavirus outbreak on a cruise ship near Cape Verde. WHO and national authorities are coordinating evacuations while tests continue.

A backend Medicare dataset left providers’ Social Security numbers exposed for weeks, prompting officials to pull the files and pledge fixes. Coverage shows providers and lawmakers want answers.

A University of Utah‑led analysis of 1900–2021 records finds suicide rates move in decades‑long cycles while youth suicide began climbing in the 1950s. The study urges prevention beyond clinics.

The FDA cleared the ProSense cryoablation system for women 70+ with small, low‑risk tumors; trials show low recurrence but surgeons say more comparative data are needed.

About 786,100 travel-size Afrin bottles were voluntarily recalled after regulators found they lack child-resistant packaging. Affected lot numbers and refund steps are listed.

A Phoenix doctor warns a rotavirus surge and a federal schedule change have made timing crucial — the rotavirus series must be finished by eight months.

ACP now advises biennial mammograms for average‑risk women 50–74, and radiologists — including a Chicago specialist — are warning it could put younger people at risk.

A Chicago survey found most patients would take an Alzheimer’s blood test, but doctors say results need confirmatory testing and counseling. Tests aren’t yet a standalone diagnosis.